These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29857523)

  • 41. Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke.
    Jia L; Chopp M; Zhang L; Lu M; Zhang Z
    Stroke; 2010 Sep; 41(9):2071-6. PubMed ID: 20671252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats.
    Michalski D; Küppers-Tiedt L; Weise C; Laignel F; Härtig W; Raviolo M; Schneider D; Hobohm C
    Brain Res; 2009 Dec; 1303():161-8. PubMed ID: 19766603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats.
    Kawamura K; Takahashi T; Kanazawa M; Igarashi H; Nakada T; Nishizawa M; Shimohata T
    PLoS One; 2014; 9(6):e98639. PubMed ID: 24896569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early use of granulocyte colony stimulating factor improves survival in a rabbit model of chronic myocardial ischemia.
    Zhao Q; Sun C; Xu X; Zhou J; Wu Y; Tian Y; Ma A; Liu Z
    J Cardiol; 2013 Jan; 61(1):87-94. PubMed ID: 23085036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of factor IX(a) is protective in a rat model of thromboembolic stroke.
    Toomey JR; Valocik RE; Koster PF; Gabriel MA; McVey M; Hart TK; Ohlstein EH; Parsons AA; Barone FC
    Stroke; 2002 Feb; 33(2):578-85. PubMed ID: 11823673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining statins with tissue plasminogen activator treatment after experimental and human stroke: a safety study on hemorrhagic transformation.
    Campos M; García-Bonilla L; Hernández-Guillamon M; Barceló V; Morancho A; Quintana M; Rubiera M; Rosell A; Montaner J
    CNS Neurosci Ther; 2013 Nov; 19(11):863-70. PubMed ID: 24118905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Granulocyte colony-stimulating factor enhances arteriogenesis and ameliorates cerebral damage in a mouse model of ischemic stroke.
    Sugiyama Y; Yagita Y; Oyama N; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K
    Stroke; 2011 Mar; 42(3):770-5. PubMed ID: 21257824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subacute intranasal administration of tissue plasminogen activator increases functional recovery and axonal remodeling after stroke in rats.
    Liu Z; Li Y; Zhang L; Xin H; Cui Y; Hanson LR; Frey WH; Chopp M
    Neurobiol Dis; 2012 Feb; 45(2):804-9. PubMed ID: 22115941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.
    Dietel B; Cicha I; Achenbach S; Kollmar R; Garlichs C; Tauchi M
    Immunol Lett; 2014; 158(1-2):95-100. PubMed ID: 24333341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
    Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke.
    García-Yébenes I; Sobrado M; Zarruk JG; Castellanos M; Pérez de la Ossa N; Dávalos A; Serena J; Lizasoain I; Moro MA
    Stroke; 2011 Jan; 42(1):196-203. PubMed ID: 21106952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood-optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION).
    Wen YT; Huang TL; Huang SP; Chang CH; Tsai RK
    Dis Model Mech; 2016 Oct; 9(10):1193-1202. PubMed ID: 27538969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of dendritic cell functions contributes to the anti-inflammatory action of granulocyte-colony stimulating factor in experimental stroke.
    Dietel B; Cicha I; Kallmünzer B; Tauchi M; Yilmaz A; Daniel WG; Schwab S; Garlichs CD; Kollmar R
    Exp Neurol; 2012 Oct; 237(2):379-87. PubMed ID: 22750328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an
    Cheon SY; Kim SY; Kam EH; Lee JH; Kim JM; Kim EJ; Kim TW; Koo BN
    Int J Med Sci; 2017; 14(5):425-433. PubMed ID: 28539818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA.
    Hafez S; Hoda MN; Guo X; Johnson MH; Fagan SC; Ergul A
    Transl Stroke Res; 2015 Jun; 6(3):171-80. PubMed ID: 25683354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Granulocyte colony-stimulating factor and bone marrow mononuclear cells for stroke treatment in the aged brain.
    Buga AM; Scheibe J; Moller K; Ciobanu O; Posel C; Boltze J; Popa-Wagner A
    Curr Neurovasc Res; 2015; 12(2):155-62. PubMed ID: 25760217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Albumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permeability and ischemic brain injury in rats.
    Tang J; Li YJ; Mu J; Li Q; Yang DY; Xie P
    Neurol Res; 2009 Mar; 31(2):189-94. PubMed ID: 19298760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
    Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
    Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
    Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
    J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.